New stroke drug trial aims to protect brain after attack
Disease control
Recruiting now
This study is testing whether a new antibody drug called TS23 can help people who recently had a stroke. Researchers want to see if TS23 is safe and if it can reduce stroke damage when given within 4.5 to 24 hours after symptoms begin. The trial will include about 300 stroke pati…
Phase: PHASE2 • Sponsor: Translational Sciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC